APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gases for Pharmaceutical and Biotechnology

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gases for Pharmaceutical and Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025181 pages

Choose your research edition.

Industry ResearchGases for Pharmaceutical and Biotechnology Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Gases for Pharmaceutical and Biotechnology Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gases for Pharmaceutical and Biotechnology Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gases for Pharmaceutical and Biotechnology Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Gases for Pharmaceutical and Biotechnology Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Gases for Pharmaceutical and Biotechnology market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gases for Pharmaceutical and Biotechnology is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gases for Pharmaceutical and Biotechnology include Air Liquide, Taiyo Nippon Sanso, Messer Group, Matheson, Air Products, Coregas, Linde and SOL Group, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

On the production side, the report examines Gases for Pharmaceutical and Biotechnology output, growth rates, and market shares by manufacturer and by region (at regional and country level) for 2021-2026, with forecasts through 2032.

On the consumption side, the report analyzes sales of Gases for Pharmaceutical and Biotechnology by region (regional and country level), company, type, and application for 2021-2026 and provides forecasts through 2032.

The report provides an overview of the global Gases for Pharmaceutical and Biotechnology market in terms of capacity, output, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gases for Pharmaceutical and Biotechnology and consumption patterns in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gases for Pharmaceutical and Biotechnology sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by type and application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Gases for Pharmaceutical and Biotechnology market size, projected growth trends, production technologies, key applications, and end-use industries.

Gases for Pharmaceutical and Biotechnology Segment by Company

Air Liquide

Taiyo Nippon Sanso

Messer Group

Matheson

Air Products

Coregas

Linde

SOL Group

Gases for Pharmaceutical and Biotechnology Segment by Type

Nitrogen

Carbon Dioxide

Oxygen

Others

Gases for Pharmaceutical and Biotechnology Segment by Application

Laboratory

Pharmaceutical and Biotechnology Companies

Others

Gases for Pharmaceutical and Biotechnology Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gases for Pharmaceutical and Biotechnology market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gases for Pharmaceutical and Biotechnology and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gases for Pharmaceutical and Biotechnology.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Gases for Pharmaceutical and Biotechnology market, including product definition, global market growth prospects, production value, capacity, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gases for Pharmaceutical and Biotechnology industry.

Chapter 3: Detailed analysis of Gases for Pharmaceutical and Biotechnology market competition landscape. Including Gases for Pharmaceutical and Biotechnology manufacturers' output value, output and average price from 2021 to 2026, as well as competition analysis indicators such as origin, product type, application, merger and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 7: Production/Production Value of Gases for Pharmaceutical and Biotechnology by region. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 8: Consumption of Gases for Pharmaceutical and Biotechnology in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Gases for Pharmaceutical and Biotechnology Industry Trends Table 2. Gases for Pharmaceutical and Biotechnology Industry Drivers Table 3. Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges Table 4. Gases for Pharmaceutical and Biotechnology Industry Restraints Table 5. Global Gases for Pharmaceutical and Biotechnology Production Value by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Manufacturers (2021-2026) Table 7. Global Gases for Pharmaceutical and Biotechnology Production by Manufacturers (Tons) & (2021-2026) Table 8. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Manufacturers Table 9. Global Gases for Pharmaceutical and Biotechnology Average Price (US$/Ton) of Manufacturers (2021-2026) Table 10. Global Gases for Pharmaceutical and Biotechnology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Gases for Pharmaceutical and Biotechnology Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Gases for Pharmaceutical and Biotechnology Manufacturers, Product Type & Application Table 13. Global Gases for Pharmaceutical and Biotechnology Manufacturers Established Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Gases for Pharmaceutical and Biotechnology by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2025) Table 16. Major Manufacturers of Nitrogen Table 17. Major Manufacturers of Carbon Dioxide Table 18. Major Manufacturers of Oxygen Table 19. Major Manufacturers of Others Table 20. Global Gases for Pharmaceutical and Biotechnology Production by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Gases for Pharmaceutical and Biotechnology Production by Type (2021-2026) & (Tons) Table 22. Global Gases for Pharmaceutical and Biotechnology Production by Type (2027-2032) & (Tons) Table 23. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2021-2026) Table 24. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2027-2032) Table 25. Global Gases for Pharmaceutical and Biotechnology Production Value by Type 2021 VS 2025 VS 2032 (Tons) Table 26. Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021-2026) & (Tons) Table 27. Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2027-2032) & (Tons) Table 28. Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Type (2021-2026) Table 29. Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Type (2027-2032) Table 30. Major Manufacturers of Laboratory Table 31. Major Manufacturers of Pharmaceutical and Biotechnology Companies Table 32. Major Manufacturers of Others Table 33. Global Gases for Pharmaceutical and Biotechnology Production by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Gases for Pharmaceutical and Biotechnology Production by Application (2021-2026) & (Tons) Table 35. Global Gases for Pharmaceutical and Biotechnology Production by Application (2027-2032) & (Tons) Table 36. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Application (2021-2026) Table 37. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Application (2027-2032) Table 38. Global Gases for Pharmaceutical and Biotechnology Production Value by Application 2021 VS 2025 VS 2032 (Tons) Table 39. Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021-2026) & (Tons) Table 40. Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2027-2032) & (Tons) Table 41. Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Application (2021-2026) Table 42. Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Application (2027-2032) Table 43. Air Liquide Company Information Table 44. Air Liquide Business Overview Table 45. Air Liquide Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio Table 47. Air Liquide Recent Development Table 48. Taiyo Nippon Sanso Company Information Table 49. Taiyo Nippon Sanso Business Overview Table 50. Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 51. Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio Table 52. Taiyo Nippon Sanso Recent Development Table 53. Messer Group Company Information Table 54. Messer Group Business Overview Table 55. Messer Group Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 56. Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio Table 57. Messer Group Recent Development Table 58. Matheson Company Information Table 59. Matheson Business Overview Table 60. Matheson Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 61. Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio Table 62. Matheson Recent Development Table 63. Air Products Company Information Table 64. Air Products Business Overview Table 65. Air Products Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 66. Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio Table 67. Air Products Recent Development Table 68. Coregas Company Information Table 69. Coregas Business Overview Table 70. Coregas Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 71. Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio Table 72. Coregas Recent Development Table 73. Linde Company Information Table 74. Linde Business Overview Table 75. Linde Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 76. Linde Gases for Pharmaceutical and Biotechnology Product Portfolio Table 77. Linde Recent Development Table 78. SOL Group Company Information Table 79. SOL Group Business Overview Table 80. SOL Group Gases for Pharmaceutical and Biotechnology Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 81. SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio Table 82. SOL Group Recent Development Table 83. Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021 VS 2025 VS 2032 (Tons) Table 84. Global Gases for Pharmaceutical and Biotechnology Production by Region (2021-2026) & (Tons) Table 85. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Region (2021-2026) Table 86. Global Gases for Pharmaceutical and Biotechnology Production Forecast by Region (2027-2032) & (Tons) Table 87. Global Gases for Pharmaceutical and Biotechnology Production Market Share Forecast by Region (2027-2032) Table 88. Global Gases for Pharmaceutical and Biotechnology Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 89. Global Gases for Pharmaceutical and Biotechnology Production Value by Region (2021-2026) & (US$ Million) Table 90. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Region (2021-2026) Table 91. Global Gases for Pharmaceutical and Biotechnology Production Value by Region (2027-2032) & (US$ Million) Table 92. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Region: (2027-2032) & (US$ Million) Table 93. Global Gases for Pharmaceutical and Biotechnology Market Average Price (US$/Ton) by Region (2021-2026) Table 94. Global Gases for Pharmaceutical and Biotechnology Market Average Price (US$/Ton) by Region (2027-2032) Table 95. Global Gases for Pharmaceutical and Biotechnology Consumption by Region: 2021 VS 2025 VS 2032 (Tons) Table 96. Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2021-2026) & (Tons) Table 97. Global Gases for Pharmaceutical and Biotechnology Consumption Market Share by Region (2021-2026) Table 98. Global Gases for Pharmaceutical and Biotechnology Consumption Forecasted by Region (2027-2032) & (Tons) Table 99. Global Gases for Pharmaceutical and Biotechnology Consumption Forecasted Market Share by Region (2027-2032) Table 100. North America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 101. North America Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2026) & (Tons) Table 102. North America Gases for Pharmaceutical and Biotechnology Consumption by Country (2027-2032) & (Tons) Table 103. Europe Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 104. Europe Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2026) & (Tons) Table 105. Europe Gases for Pharmaceutical and Biotechnology Consumption by Country (2027-2032) & (Tons) Table 106. Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 107. Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2026) & (Tons) Table 108. Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption by Country (2027-2032) & (Tons) Table 109. South America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 110. South America Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2026) & (Tons) Table 111. South America Gases for Pharmaceutical and Biotechnology Consumption by Country (2027-2032) & (Tons) Table 112. Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032 (Tons) Table 113. Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2026) & (Tons) Table 114. Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption by Country (2027-2032) & (Tons) Table 115. Key Raw Materials Table 116. Raw Materials Key Suppliers Table 117. Gases for Pharmaceutical and Biotechnology Distributors List Table 118. Gases for Pharmaceutical and Biotechnology Customers List Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. Gases for Pharmaceutical and Biotechnology Product Image Figure 2. Global Gases for Pharmaceutical and Biotechnology Production Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 4. Global Gases for Pharmaceutical and Biotechnology Production Capacity (2021-2032) & (Tons) Figure 5. Global Gases for Pharmaceutical and Biotechnology Production (2021-2032) & (Tons) Figure 6. Global Gases for Pharmaceutical and Biotechnology Average Price (US$/Ton) & (2021-2032) Figure 7. Global Top 5 and 10 Gases for Pharmaceutical and Biotechnology Players Market Share by Production Value in 2025 Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nitrogen Image Figure 10. Carbon Dioxide Image Figure 11. Oxygen Image Figure 12. Others Image Figure 13. Global Gases for Pharmaceutical and Biotechnology Production by Type (2021 VS 2025 VS 2032) & (Tons) Figure 14. Global Gases for Pharmaceutical and Biotechnology Production Market Share 2021 VS 2025 VS 2032 Figure 15. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2021-2032) Figure 16. Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021 VS 2025 VS 2032) & (Tons) Figure 17. Global Gases for Pharmaceutical and Biotechnology Production Value Share 2021 VS 2025 VS 2032 Figure 18. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Type (2021-2032) Figure 19. Laboratory Image Figure 20. Pharmaceutical and Biotechnology Companies Image Figure 21. Others Image Figure 22. Global Gases for Pharmaceutical and Biotechnology Production by Application (2021 VS 2025 VS 2032) & (Tons) Figure 23. Global Gases for Pharmaceutical and Biotechnology Production Market Share 2021 VS 2025 VS 2032 Figure 24. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Application (2021-2032) Figure 25. Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021 VS 2025 VS 2032) & (Tons) Figure 26. Global Gases for Pharmaceutical and Biotechnology Production Value Share 2021 VS 2025 VS 2032 Figure 27. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Application (2021-2032) Figure 28. Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021 VS 2025 VS 2032 (Tons) Figure 29. Global Gases for Pharmaceutical and Biotechnology Production Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Gases for Pharmaceutical and Biotechnology Production Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Gases for Pharmaceutical and Biotechnology Production Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 33. Europe Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 35. South America Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Gases for Pharmaceutical and Biotechnology Production Value (2021-2032) & (US$ Million) Figure 37. North America Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 38. North America Gases for Pharmaceutical and Biotechnology Consumption Market Share by Country (2021-2032) Figure 39. U.S. Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 40. Canada Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 41. Mexico Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 42. Europe Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 43. Europe Gases for Pharmaceutical and Biotechnology Consumption Market Share by Country (2021-2032) Figure 44. Germany Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 45. France Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 46. U.K. Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 47. Italy Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 48. Netherlands Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 49. Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 50. Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption Market Share by Country (2021-2032) Figure 51. China Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 52. Japan Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 53. South Korea Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 54. Southeast Asia Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 55. India Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 56. Australia Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 57. South America Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 58. South America Gases for Pharmaceutical and Biotechnology Consumption Market Share by Country (2021-2032) Figure 59. Brazil Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 60. Argentina Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 61. Chile Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 62. Colombia Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 63. Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 64. Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption Market Share by Country (2021-2032) Figure 65. Egypt Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 66. South Africa Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 67. Israel Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 68. Türkiye Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 69. GCC Countries Gases for Pharmaceutical and Biotechnology Consumption and Growth Rate (2021-2032) & (Tons) Figure 70. Gases for Pharmaceutical and Biotechnology Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Gases for Pharmaceutical and Biotechnology Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Nitrogen
  • Carbon Dioxide
  • Oxygen
  • Others
Applications
  • Laboratory
  • Pharmaceutical and Biotechnology Companies
  • Others
Companies covered
  • Air Liquide
  • Taiyo Nippon Sanso
  • Messer Group
  • Matheson
  • Air Products
  • Coregas
  • Linde
  • SOL Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Gases for Pharmaceutical and Biotechnology Production Value Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Gases for Pharmaceutical and Biotechnology Production Capacity Estimates and Forecasts (2021-2032)
  5. 1.2.3 Global Gases for Pharmaceutical and Biotechnology Production Estimates and Forecasts (2021-2032)
  6. 1.2.4 Global Gases for Pharmaceutical and Biotechnology Market Average Price (2021-2032)
  7. 1.3 Assumptions and Limitations
  8. 1.4 Study Goals and Objectives
2 Global Gases for Pharmaceutical and Biotechnology Market Dynamics
  1. 2.1 Gases for Pharmaceutical and Biotechnology Industry Trends
  2. 2.2 Gases for Pharmaceutical and Biotechnology Industry Drivers
  3. 2.3 Gases for Pharmaceutical and Biotechnology Industry Opportunities and Challenges
  4. 2.4 Gases for Pharmaceutical and Biotechnology Industry Restraints
3 Gases for Pharmaceutical and Biotechnology Market by Manufacturers
  1. 3.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Manufacturers (2021-2026)
  2. 3.2 Global Gases for Pharmaceutical and Biotechnology Production by Manufacturers (2021-2026)
  3. 3.3 Global Gases for Pharmaceutical and Biotechnology Average Price by Manufacturers (2021-2026)
  4. 3.4 Global Gases for Pharmaceutical and Biotechnology Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Gases for Pharmaceutical and Biotechnology Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Gases for Pharmaceutical and Biotechnology Manufacturers, Product Type & Application
  7. 3.7 Global Gases for Pharmaceutical and Biotechnology Manufacturers Established Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Gases for Pharmaceutical and Biotechnology Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Gases for Pharmaceutical and Biotechnology Players Market Share by Production Value in 2025
  11. 3.8.3 2025 Gases for Pharmaceutical and Biotechnology Tier 1, Tier 2, and Tier 3
4 Gases for Pharmaceutical and Biotechnology Market by Type
  1. 4.1 Gases for Pharmaceutical and Biotechnology Type Introduction
  2. 4.1.1 Nitrogen
  3. 4.1.2 Carbon Dioxide
  4. 4.1.3 Oxygen
  5. 4.1.4 Others
  6. 4.2 Global Gases for Pharmaceutical and Biotechnology Production by Type
  7. 4.2.1 Global Gases for Pharmaceutical and Biotechnology Production by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Gases for Pharmaceutical and Biotechnology Production by Type (2021-2032)
  9. 4.2.3 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Type (2021-2032)
  10. 4.3 Global Gases for Pharmaceutical and Biotechnology Production Value by Type
  11. 4.3.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Type (2021-2032)
  13. 4.3.3 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Type (2021-2032)
5 Gases for Pharmaceutical and Biotechnology Market by Application
  1. 5.1 Gases for Pharmaceutical and Biotechnology Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Pharmaceutical and Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Gases for Pharmaceutical and Biotechnology Production by Application
  6. 5.2.1 Global Gases for Pharmaceutical and Biotechnology Production by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gases for Pharmaceutical and Biotechnology Production by Application (2021-2032)
  8. 5.2.3 Global Gases for Pharmaceutical and Biotechnology Production Market Share by Application (2021-2032)
  9. 5.3 Global Gases for Pharmaceutical and Biotechnology Production Value by Application
  10. 5.3.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Application (2021-2032)
  12. 5.3.3 Global Gases for Pharmaceutical and Biotechnology Production Value Market Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Air Liquide
  2. 6.1.1 Air Liquide Company Information
  3. 6.1.2 Air Liquide Business Overview
  4. 6.1.3 Air Liquide Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  5. 6.1.4 Air Liquide Gases for Pharmaceutical and Biotechnology Product Portfolio
  6. 6.1.5 Air Liquide Recent Developments
  7. 6.2 Taiyo Nippon Sanso
  8. 6.2.1 Taiyo Nippon Sanso Company Information
  9. 6.2.2 Taiyo Nippon Sanso Business Overview
  10. 6.2.3 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  11. 6.2.4 Taiyo Nippon Sanso Gases for Pharmaceutical and Biotechnology Product Portfolio
  12. 6.2.5 Taiyo Nippon Sanso Recent Developments
  13. 6.3 Messer Group
  14. 6.3.1 Messer Group Company Information
  15. 6.3.2 Messer Group Business Overview
  16. 6.3.3 Messer Group Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  17. 6.3.4 Messer Group Gases for Pharmaceutical and Biotechnology Product Portfolio
  18. 6.3.5 Messer Group Recent Developments
  19. 6.4 Matheson
  20. 6.4.1 Matheson Company Information
  21. 6.4.2 Matheson Business Overview
  22. 6.4.3 Matheson Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  23. 6.4.4 Matheson Gases for Pharmaceutical and Biotechnology Product Portfolio
  24. 6.4.5 Matheson Recent Developments
  25. 6.5 Air Products
  26. 6.5.1 Air Products Company Information
  27. 6.5.2 Air Products Business Overview
  28. 6.5.3 Air Products Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  29. 6.5.4 Air Products Gases for Pharmaceutical and Biotechnology Product Portfolio
  30. 6.5.5 Air Products Recent Developments
  31. 6.6 Coregas
  32. 6.6.1 Coregas Company Information
  33. 6.6.2 Coregas Business Overview
  34. 6.6.3 Coregas Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  35. 6.6.4 Coregas Gases for Pharmaceutical and Biotechnology Product Portfolio
  36. 6.6.5 Coregas Recent Developments
  37. 6.7 Linde
  38. 6.7.1 Linde Company Information
  39. 6.7.2 Linde Business Overview
  40. 6.7.3 Linde Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  41. 6.7.4 Linde Gases for Pharmaceutical and Biotechnology Product Portfolio
  42. 6.7.5 Linde Recent Developments
  43. 6.8 SOL Group
  44. 6.8.1 SOL Group Company Information
  45. 6.8.2 SOL Group Business Overview
  46. 6.8.3 SOL Group Gases for Pharmaceutical and Biotechnology Production, Value and Gross Margin (2021-2026)
  47. 6.8.4 SOL Group Gases for Pharmaceutical and Biotechnology Product Portfolio
  48. 6.8.5 SOL Group Recent Developments
7 Global Gases for Pharmaceutical and Biotechnology Production by Region
  1. 7.1 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021 VS 2025 VS 2032
  2. 7.2 Global Gases for Pharmaceutical and Biotechnology Production by Region (2021-2032)
  3. 7.2.1 Global Gases for Pharmaceutical and Biotechnology Production by Region (2021-2026)
  4. 7.2.2 Global Gases for Pharmaceutical and Biotechnology Production Forecast by Region (2027-2032)
  5. 7.3 Global Gases for Pharmaceutical and Biotechnology Production by Region: 2021 VS 2025 VS 2032
  6. 7.4 Global Gases for Pharmaceutical and Biotechnology Production Value by Region (2021-2032)
  7. 7.4.1 Global Gases for Pharmaceutical and Biotechnology Production Value by Region (2021-2026)
  8. 7.4.2 Global Gases for Pharmaceutical and Biotechnology Production Value by Region (2027-2032)
  9. 7.5 Global Gases for Pharmaceutical and Biotechnology Market Price Analysis by Region (2021-2032)
  10. 7.6 Regional Production Value Trends (2021-2032)
  11. 7.6.1 North America Gases for Pharmaceutical and Biotechnology Production Value (2021-2032)
  12. 7.6.2 Europe Gases for Pharmaceutical and Biotechnology Production Value (2021-2032)
  13. 7.6.3 Asia-Pacific Gases for Pharmaceutical and Biotechnology Production Value (2021-2032)
  14. 7.6.4 South America Gases for Pharmaceutical and Biotechnology Production Value (2021-2032)
  15. 7.6.5 Middle East & Africa Gases for Pharmaceutical and Biotechnology Production Value (2021-2032)
8 Global Gases for Pharmaceutical and Biotechnology Consumption by Region
  1. 8.1 Global Gases for Pharmaceutical and Biotechnology Consumption by Region: 2021 VS 2025 VS 2032
  2. 8.2 Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2021-2032)
  3. 8.2.1 Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2021-2026)
  4. 8.2.2 Global Gases for Pharmaceutical and Biotechnology Consumption by Region (2027-2032)
  5. 8.3 North America
  6. 8.3.1 North America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 8.3.2 North America Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
  8. 8.3.3 U.S.
  9. 8.3.4 Canada
  10. 8.3.5 Mexico
  11. 8.4 Europe
  12. 8.4.1 Europe Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 8.4.2 Europe Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
  14. 8.4.3 Germany
  15. 8.4.4 France
  16. 8.4.5 U.K.
  17. 8.4.6 Italy
  18. 8.4.7 Netherlands
  19. 8.5 Asia Pacific
  20. 8.5.1 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 8.5.2 Asia Pacific Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
  22. 8.5.3 China
  23. 8.5.4 Japan
  24. 8.5.5 South Korea
  25. 8.5.6 Southeast Asia
  26. 8.5.7 India
  27. 8.5.8 Australia
  28. 8.6 South America
  29. 8.6.1 South America Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 8.6.2 South America Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
  31. 8.6.3 Brazil
  32. 8.6.4 Argentina
  33. 8.6.5 Chile
  34. 8.6.6 Colombia
  35. 8.7 Middle East & Africa
  36. 8.7.1 Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
  37. 8.7.2 Middle East & Africa Gases for Pharmaceutical and Biotechnology Consumption by Country (2021-2032)
  38. 8.7.3 Egypt
  39. 8.7.4 South Africa
  40. 8.7.5 Israel
  41. 8.7.6 Türkiye
  42. 8.7.7 GCC Countries
9 Value Chain and Sales Channels Analysis
  1. 9.1 Gases for Pharmaceutical and Biotechnology Value Chain Analysis
  2. 9.1.1 Gases for Pharmaceutical and Biotechnology Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Gases for Pharmaceutical and Biotechnology Production Mode & Process
  6. 9.2 Gases for Pharmaceutical and Biotechnology Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Gases for Pharmaceutical and Biotechnology Distributors
  9. 9.2.3 Gases for Pharmaceutical and Biotechnology Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst